Najar Mehdi, Krayem Mohammad, Meuleman Nathalie, Bron Dominique, Hélène Busser, Lagneaux Laurence
Laboratory of Clinical Cell Therapy, Institut Jules Bordet, Université Libre de Bruxelles (ULB)/Campus Erasme.
Laboratory of Oncology and Experimental Surgery.
Appl Immunohistochem Mol Morphol. 2018 Mar;26(3):e26-e43. doi: 10.1097/PAI.0000000000000629.
Mesenchymal stromal cells (MSC) are nonhematopoietic cells that can be isolated from several adult and fetal tissues. MSC present specific features as the capacity to support hematopoiesis and to regulate immune response. Thus, the use of MSC as a cell therapeutic product in the field of immune-hematology is of great importance. In this review, we focused on human MSC and discussed their immune-hematologic properties and their translation toward therapeutic clinical applications. Thus, these features hold great promise for cell-based therapy and are of important relevance for the field.
间充质基质细胞(MSC)是一类非造血细胞,可从多种成人及胎儿组织中分离得到。MSC具有支持造血和调节免疫反应的特定特性。因此,将MSC用作免疫血液学领域的细胞治疗产品具有重要意义。在本综述中,我们聚焦于人类MSC,并讨论了它们的免疫血液学特性以及向治疗性临床应用的转化。因此,这些特性为基于细胞的治疗带来了巨大希望,并且对该领域具有重要意义。